$-0.84 EPS Expected for Syndax Pharmaceuticals (SNDX), Renn Global Entrepreneurs Fund (RENN)’s Sentiment Is 0.28

July 27, 2017 - By Adrian Mccoy

Analysts expect Syndax Pharmaceuticals Inc (NASDAQ:SNDX) to report $-0.84 EPS on August, 8.They anticipate $0.37 EPS change or 78.72% from last quarter’s $-0.47 EPS. After having $-0.71 EPS previously, Syndax Pharmaceuticals Inc’s analysts see 18.31% EPS growth. About 17,864 shares traded. Syndax Pharmaceuticals Inc (NASDAQ:SNDX) has risen 7.09% since July 27, 2016 and is uptrending. It has underperformed by 9.61% the S&P500.

Renren Inc. operates a real name social networking Internet platform in China. The company has market cap of $477.00 million. The Firm enables users to connect and communicate with each other, share photos, and various features and services. It currently has negative earnings. The Firm is developing Internet finance business to leverage its social networking services and user base in China, particularly focusing on the audience of college students and young people in China.

Syndax Pharmaceuticals, Inc is a clinical stage biopharmaceutical firm focused on developing a pipeline of combination therapies in multiple cancer indications. The company has market cap of $284.20 million. The Company’s product candidate, entinostat, which was granted Breakthrough Therapy designation by the FDA following positive results from its Phase IIb clinical trial, ENCORE 301, is being evaluated in a Phase III clinical trial for advanced hormone receptor positive breast cancer. It currently has negative earnings. It is developing entinostat, which has direct effects on both cancer cells and immune regulatory cells, and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body’s immune response on tumors that have shown sensitivity to immunotherapy.

Top Ace Asset Management Ltd holds 0.89% of its portfolio in Renren Inc for 500,000 shares. Oberweis Asset Management Inc owns 150,000 shares or 0.07% of their US portfolio. Moreover, Bluecrest Capital Management Ltd has 0.01% invested in the company for 102,813 shares. The New York-based Global X Management Co Llc has invested 0.01% in the stock. Aperio Group Llc, a California-based fund reported 26,398 shares.

About 262,942 shares traded or 86.99% up from the average. Renren Inc (RENN) has declined 19.34% since July 27, 2016 and is downtrending. It has underperformed by 36.04% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com